60 related articles for article (PubMed ID: 3705525)
1. [Cisplatin (platidiame) in the treatment of patients with disseminated breast cancer].
Sopkova V; Mechl Z
Vopr Onkol; 1986; 32(4):36-8. PubMed ID: 3705525
[TBL] [Abstract][Full Text] [Related]
2. High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.
Ostrow S; Egorin M; Aisner J; Bachur N; Wiernik PH
Cancer Clin Trials; 1980; 3(1):23-7. PubMed ID: 7190082
[TBL] [Abstract][Full Text] [Related]
3. Platinum-based chemotherapy in metastatic breast cancer: current status.
Decatris MP; Sundar S; O'Byrne KJ
Cancer Treat Rev; 2004 Feb; 30(1):53-81. PubMed ID: 14766126
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of hexamethylmelamine, cis-diamminedichloroplatinum, and mitomycin-C in advanced breast cancer. A pilot study of the Southeastern Cancer Study Group.
Lawson D; Moore M; Smalley R
Cancer Clin Trials; 1980; 3(4):293-6. PubMed ID: 6775826
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.
Orlando L; Colleoni M; Curigliano G; Nolè F; Ferretti G; Masci G; Peruzzotti G; Minchella I; Intra M; Veronesi P; Viale G; Goldhirsch A
Anticancer Res; 2001; 21(6A):4135-9. PubMed ID: 11911307
[TBL] [Abstract][Full Text] [Related]
6. [Experiences with cisplatin (Platidiam) chemotherapy in secondary resistant ovarian carcinomas].
Krafft W; Mechl Z; Behling H; Brückmann D; Preibsch W; Kademann J; Schirmer A
Zentralbl Gynakol; 1984; 106(3):175-83. PubMed ID: 6538371
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study.
Booth CM; Clemons M; Dranitsaris G; Joy A; Young S; Callaghan W; Trudeau M; Petrella T
J Support Oncol; 2007 Sep; 5(8):374-80. PubMed ID: 17944146
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of ramosetron hydrochloride on nausea and vomiting in CMF or CEF therapy for breast cancer].
Taguchi T; Tsukamoto F; Watanabe T; Yoneda K; Takamura Y; Hojo S; Shiba E; Noguchi S
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1163-70. PubMed ID: 10431583
[TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
Shih V; Wan HS; Chan A
Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic effect of acupuncture on cisplatin-induced nausea and vomiting].
Sima L; Wang X
Zhongguo Zhen Jiu; 2009 Jan; 29(1):3-6. PubMed ID: 19186712
[TBL] [Abstract][Full Text] [Related]
11. Cis-diamminedichloroplatinum in the treatment of disseminated malignant melanoma.
Mechl Z; Krejcí P
Neoplasma; 1983; 30(3):371-7. PubMed ID: 6683360
[TBL] [Abstract][Full Text] [Related]
12. Interim results of a phase I/II study of biweekly paclitaxel and cisplatin in patients with metastatic breast cancer.
Tolcher AW; Gelmon KA
Semin Oncol; 1995 Aug; 22(4 Suppl 8):28-32. PubMed ID: 7638639
[TBL] [Abstract][Full Text] [Related]
13. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
[TBL] [Abstract][Full Text] [Related]
14. CAP (cyclophosphamide, adriamycin, cisplatinum) in the treatment of advanced breast cancer.
Mechl Z; Sopková B
Neoplasma; 1984; 31(4):431-5. PubMed ID: 6547999
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of cis-diamminedichloroplatinum in patients with non-small cell lung cancer.
Fujita J; Saijo N; Eguchi K; Shimizu E; Shinkai T; Tominaga K; Sasaki Y; Futami H; Sakurai M; Hoshi A
Jpn J Cancer Res; 1985 May; 76(5):420-3. PubMed ID: 3924714
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
17. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
Klaassen U; Wilke H; Müller C; Borquez D; Harstrick A; Seeber S
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
[TBL] [Abstract][Full Text] [Related]
18. [Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy].
Niijima T; Isurugi K; Akaza H; Kondo Y; Kawabe K; Fujita K; Koiso K; Yokoyama M; Kinoshita K; Aso Y
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2376-82. PubMed ID: 3729492
[TBL] [Abstract][Full Text] [Related]
19. [Use of tamoxifen in patients with disseminated and local breast neoplasms].
Semiglazov VF; Gershanovich ML; Kondrat'ev VB; Moiseenko VM
Vopr Onkol; 1984; 30(9):39-43. PubMed ID: 6495691
[TBL] [Abstract][Full Text] [Related]
20. [Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin].
Tanimura S; Banba J; Tomoyasu H; Masaki M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2275-81. PubMed ID: 9881085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
